Get the Stockscreener App
20.62
0.05%
0.01
After Hours:
20.60
-0.02
-0.10%
Mbx Biosciences Inc stock is traded at $20.62, with a volume of 757.95K.
It is up +0.05% in the last 24 hours and up +23.55% over the past month.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
See More
Previous Close:
$20.61
Open:
$20.78
24h Volume:
757.95K
Relative Volume:
0.62
Market Cap:
$692.71M
Revenue:
-
Net Income/Loss:
$-47.20M
P/E Ratio:
-13.17
EPS:
-1.5653
Net Cash Flow:
$-43.65M
1W Performance:
+14.81%
1M Performance:
+23.55%
6M Performance:
+71.83%
1Y Performance:
-5.67%
1-Day Range:
$20.27
$22.16
1-Week Range:
$17.92
$22.53
52-Week Range:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Name
Mbx Biosciences Inc
Sector
Industry
Phone
(317) 989-3100
Address
11711 N. MERIDIAN STREET, CARMEL
Compare MBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
20.62 | 921.59M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Aug-15-25 | Resumed | Jefferies | Buy |
| Aug-05-25 | Initiated | Mizuho | Outperform |
| Jul-16-25 | Initiated | Oppenheimer | Outperform |
| Apr-10-25 | Initiated | Citizens JMP | Mkt Outperform |
| Oct-08-24 | Initiated | Guggenheim | Buy |
| Oct-08-24 | Initiated | JP Morgan | Overweight |
| Oct-08-24 | Initiated | Jefferies | Buy |
| Oct-08-24 | Initiated | Stifel | Buy |
View All
Mbx Biosciences Inc Stock (MBX) Latest News
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
TD Cowen Initiates MBX Biosciences at Buy - MarketScreener
TD Cowen initiates MBX Biosciences stock with Buy rating on strong platform - Investing.com
Buy Rating for MBX Biosciences Driven by Promising PEP Platform and Successful Phase II Trials - TipRanks
Chart based exit strategy for MBX Biosciences Inc.Weekly Market Summary & Weekly High Return Opportunities - newser.com
Using flow based indicators on MBX Biosciences Inc.Weekly Risk Summary & Long-Term Capital Growth Ideas - newser.com
How rising interest rates impact MBX Biosciences Inc. stockMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
How to interpret RSI for MBX Biosciences Inc. stock2025 Dividend Review & Safe Capital Investment Plans - newser.com
What technical signals suggest for MBX Biosciences Inc. stock2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
How to read the order book for MBX Biosciences Inc.2025 Trade Ideas & Weekly Momentum Picks - newser.com
MBX Biosciences Inc. stock trend outlook and recovery path2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com
Why MBX Biosciences Inc. stock remains on buy listsTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Predicting MBX Biosciences Inc. trend using moving averages2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
What Wall Street predicts for MBX Biosciences Inc. stock priceRate Cut & Daily Profit Maximizing Trade Tips - newser.com
Can MBX Biosciences Inc. hit a new high this monthQuarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Sentiment analysis tools applied to MBX Biosciences Inc.2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
Will MBX Biosciences Inc. stock go up soonProfit Target & Daily Technical Stock Forecast Reports - newser.com
Visualizing MBX Biosciences Inc. stock with heatmaps2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
What machine learning models say about MBX Biosciences Inc.July 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Detecting price anomalies in MBX Biosciences Inc. with AI2025 Market WrapUp & Safe Capital Growth Tips - newser.com
What sentiment indicators say about MBX Biosciences Inc. stock2025 Trade Ideas & High Conviction Investment Ideas - newser.com
Does MBX Biosciences Inc. fit your quant trading modelGap Down & High Yield Equity Trading Tips - newser.com
What indicators show strength in MBX Biosciences Inc.Portfolio Update Report & Proven Capital Preservation Methods - newser.com
Using fundamentals and technicals on MBX Biosciences Inc.2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Is MBX Biosciences Inc. stock positioned for long term growth2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Published on: 2025-11-01 03:05:26 - newser.com
Published on: 2025-10-31 05:55:09 - newser.com
Relative strength of MBX Biosciences Inc. in sector analysisQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Why MBX Biosciences Inc. stock is favored by pension fundsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Mbx Biosciences Inc Stock (MBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):